(function(){var loadHandler=window['sl_{EC00A760-FAC2-48CD-8603-FA3C7FB92E6B}'];loadHandler&&loadHandler(7, '<div id="spr0_3652df2"><div id="spr1_3652df2" class="kern slide"><img id="img2_3652df2" src="data/img9.png" width="1280px" height="720px" alt="" style="left:0px;top:0px;"/></div><div id="spr2_3652df2" class="kern slide"><div id="spr3_3652df2" style="left:68.129px;top:66.065px;"><div style="width:0px;"><span id="txt0_3652df2" data-width="172.102859" style="left:9.6px;top:1.215px;">Emerging</span></div><div style="width:0px;"><span id="txt1_3652df2" data-width="310.847656" style="left:9.6px;top:50.175px;">technologies and</span></div><div style="width:0px;"><span id="txt2_3652df2" data-width="346.552063" style="left:9.6px;top:99.135px;">changing paradigm</span></div></div><div id="spr4_3652df2" style="left:68.129px;top:256.516px;"><div style="width:0px;"><span id="txt3_3652df2" data-width="326.302063" style="left:9.6px;top:-1.38px;">From drug-centred to patient-</span></div><div style="width:0px;"><span id="txt4_3652df2" data-width="185.703125" style="left:9.6px;top:27.42px;">centred studies…</span></div><div style="width:0px;"><span id="txt5_3652df2" data-width="316.445313" style="left:9.6px;top:68.784px;">“N-of-1” trials, each patient’s</span></div><div style="width:0px;"><span id="txt6_3652df2" data-width="259.075500" style="left:9.6px;top:98.353px;">treatment is considered</span></div><div style="width:0px;"><span id="txt7_3652df2" data-width="277.304688" style="left:9.6px;top:127.153px;">separately on the basis of</span></div><div style="width:0px;"><span id="txt8_3652df2" data-width="330.000000" style="left:9.6px;top:155.953px;">molecular, immune, and other</span></div><div style="width:0px;"><span id="txt9_3652df2" data-width="323.294250" style="left:9.6px;top:184.753px;">biologic characteristics. These</span></div><div style="width:0px;"><span id="txt10_3652df2" data-width="323.242188" style="left:9.6px;top:213.553px;">trials involve customized drug</span></div><div style="width:0px;"><span id="txt11_3652df2" data-width="266.744781" style="left:9.6px;top:242.353px;">combinations tailored to</span></div><div style="width:0px;"><span id="txt12_3652df2" data-width="347.890625" style="left:9.6px;top:271.153px;">individual patients. Determining</span></div><div style="width:0px;"><span id="txt13_3652df2" data-width="362.252594" style="left:9.6px;top:299.953px;">efficacy in “N-of-1” trials requires</span></div><div style="width:0px;"><span id="txt14_3652df2" data-width="287.513000" style="left:9.6px;top:328.753px;">assessing the “strategy” of</span></div><div style="width:0px;"><span id="txt15_3652df2" data-width="371.093750" style="left:9.6px;top:357.553px;">matching patients to drugs, rather</span></div><div style="width:0px;"><span id="txt16_3652df2" data-width="319.062500" style="left:9.6px;top:386.353px;">than treatments, which differ</span></div><div style="width:0px;"><span id="txt17_3652df2" data-width="268.385406" style="left:9.6px;top:415.153px;">from patient to patient…</span></div></div><div id="svg0_3652df2" style="left:487.04px;"><svg width="793" height="720" viewBox="0 0 793 720"><path fill="#c8caca" d="M0,0 h792.96 v720 h-792.96 Z"/></svg></div><div id="spr5_3652df2" style="left:531.42px;top:54.06px;"><img id="img0_3652df2" src="data/img25.png" width="703.5" height="616.5" alt="" style="left:0.279px;top:-0.36px;"/></div><div id="spr6_3652df2" style="left:567.545px;top:96.78px;"><img id="img1_3652df2" src="data/img26.png" width="631.5" height="526.5" alt="Graphical user interface  Description automatically generated" style="left:0.169px;top:-0.15px;"/></div></div></div>', '{"s":[]}');})();